| Health / Medical Topics |
Glioma-Associated Antigen Peptide-Pulsed Autologous Dendritic Cell Vaccine
A cancer vaccine comprised of autologous dendritic cells pulsed with synthetic glioma-associated antigen (GAA) peptides with potential antineoplastic activity. Upon administration, this vaccine may stimulate anti-tumoral cytotoxic T lymphocyte (CTL) and antibody responses against GAA peptide-expressing glioma cells, resulting in tumor cell lysis. (NCI Thesaurus)
YOU MAY ALSO LIKE
Glioma tumor suppressor candidate region gene 2 protein (478 aa, ~54 kDa) is encoded by the human GLTSCR2 gene. This protein may…
Glioma Tumor Suppressor Candidate Region Gene 1 Protein is encoded by the human GLTSCR1 gene. This protein is expressed at moderate levels…
A group of of six collaborating laboratories at medical centers located throughout the U.S. working to identify new molecular alterations that may…
A cancer of the brain that begins in glial cells (cells that surround and support nerve cells).
An astrocytic tumor affecting young people. Morphologically, it is characterized by the presence of collagenous tissue surrounding neoplastic astrocytes. In…
Glioblastoma multiforme (GBM) formation is either de novo (primary GBMs) or due to the progression of a lower grade glioma to a…
